Core Viewpoint - Ascentage Pharma Group International is set to provide an update on its innovative portfolio and pipeline during an investor webcast, focusing on key presentations at the upcoming 67th American Society of Hematology Annual Meeting [1]. Company Overview - Ascentage Pharma is a global, commercial stage, integrated biopharmaceutical company dedicated to discovering, developing, and commercializing novel therapies for unmet medical needs in cancer [4]. - The company has developed a rich pipeline of innovative drug products, including inhibitors targeting key apoptotic pathway proteins and next-generation kinase inhibitors [4]. Product Pipeline - The first approved product, Olverembatinib, is a third-generation BCR-ABL1 inhibitor for treating chronic myeloid leukemia (CML) with specific mutations and is included in the China National Reimbursement Drug List [5]. - The company is conducting a global registrational Phase III trial (POLARIS-2) for Olverembatinib in CML and additional trials for newly diagnosed Ph+ acute lymphoblastic leukemia (ALL) and SDH-deficient gastrointestinal stromal tumors (GIST) [5]. - The second approved product, Lisaftoclax, is a Bcl-2 inhibitor for various hematologic malignancies and is undergoing multiple global registrational Phase III trials [6]. Research and Development - Ascentage Pharma has established a portfolio of global intellectual property rights and formed partnerships with leading biotechnology and pharmaceutical companies, including Takeda, AstraZeneca, Merck, and Pfizer [7].

Premieres to Over 125 Million Pay Cable Subscribers and Free Streaming Viewers Via Envoy TV and Envoy FAST Channels, Dr. Phil Combined Social Following Tops 27 Million Network Debuts With More Than 200 Podcasts and 15,000 Hours of Premium Library Content Drawn From the Combined Catalogs of PodcastOne and Envoy Media Co. LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- LiveOne (NASDAQ: LVO) announced today that its subsidiary PodcastOne (NASDAQ: PODC) and Dr. Phil’s Envoy Media Co. have partnered to launch a c ...

AI study to begin with Kitimat Copper-Gold Project; Copper Quest completes initial site visit and work programVANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Copper Quest Exploration Inc. (CSE: CQX; OTCQB: IMIMF; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce it has entered into a strategic partnership with U.S. based Exploration Technologies Inc. (“ExploreTech”) to deploy generative artificial intelligence across its project portfolio, beginning with the Kitimat Copper-Go ...

Ground-Based Gravity Survey Launching in December to Follow Up on Historic Uranium Intercepts First Defined by Cameco and Denison MinesVANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company"), Foremost Clean Energy Ltd. (NASDAQ: FMST) is pleased to announce that the Saskatchewan Ministry of Environment has issued a three-year exploration permit for the Company’s Turkey Lake Uranium Project (“Turkey Lake”), located on th ...

– SGT-212 has been granted FDA Rare Pediatric Disease and Fast Track designations – – SGT-212 is the only dual route gene therapy in development to treat Friedreich’s ataxia – – FALCON Phase 1b clinical trial participant screening underway – CHARLESTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it received Rare Pediatric ...

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary ADAR-mediated Axiomer™ RNA editing technology platform, today announced that the Company will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Thursday, December 4, 2025 at 8:20am ET. Webcast details will be accessible from the “Investors & Media” section ...

VANCOUVER, British Columbia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) ("SHARC Energy" or the “Company”) is pleased to announce it has filed financial results for the three and nine months ended September 30, 2025. All figures are in Canadian Dollars and in accordance with IFRS unless otherwise stated. Third Quarter and Year to Date (YTD) Financial Highlights: Revenue for the nine months ended September 30, 2025 (“YTD 2025”) is $2.69 million (M ...

HOUSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.08 per share for December 2025. This distribution is payable to common stockholders on December 31, 2025 (as outlined in the table below). The Company declares and pays distributions on a monthly basis. Payment of future distributions is subject to the approval of the Company’s Board of Directors, as well as meeting the covenants on the Company’s debt agreem ...

TORONTO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Stack Capital Group Inc. (“Stack Capital” or the “Company”) (TSX:STCK; TSX:STCK.WT.A; TSX:STCK.WT.B) announced today that the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by Stack Capital of its intention to make a normal course issuer bid (the “NCIB”) with respect to its outstanding common shares. Stack Capital management believes its share price is undervalued compared to its recently announced Book Value per Share of $14.26. The notice provides ...

KUALA LUMPUR, Malaysia, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored technology company, today announced an ambitious projection of more than 500% revenue growth for 2026. This anticipated surge is supported by several key operational milestones achieved across its fintech and digital asset ecosystem. These strategic advancements, including the development of the OXI Wallet, the UNIRWA real-world asset (RWA) tokenization ...